January 23, 2004 - Volume 18 - Issue 2 - Contributor Index

Alphabetical Search
Q
U
X

Timing of mother-to-child transmission of HIV-1 and infant mortality in the first 6 months of life in Harare, Zimbabwe

Zijenah, Lynn S; Moulton, Lawrence H; Iliff, Peter; More

AIDS . 18(2):273-280, January 23, 2004.

Timing of mother-to-child transmission of HIV-1 and infant mortality in the first 6 months of life in Harare, Zimbabwe

Zijenah, Lynn S; Moulton, Lawrence H; Iliff, Peter; More

AIDS . 18(2):273-280, January 23, 2004.

Author:
Zijenah, Lynn S

Timing of mother-to-child transmission of HIV-1 and infant mortality in the first 6 months of life in Harare, Zimbabwe

Zijenah, Lynn S; Moulton, Lawrence H; Iliff, Peter; More

AIDS . 18(2):273-280, January 23, 2004.

Author:
Zhou, Yong-Xin
Author:
Young, Mary
Author:
Yndestad, Arne
Author:
Yang, Otto O

HIV-1 Nef protein in the nucleus influences adipogenesis as well as viral transcription through the peroxisome proliferator-activated receptors

Otake, Kaori; Omoto, Shinya; Yamamoto, Takuya; More

AIDS . 18(2):189-198, January 23, 2004.

Author:
Wit, John BFde
Author:
Whitby, Denise

Amino acid residue at position 13 in HLA-DR beta chain plays a critical role in the development of Kaposi's sarcoma in AIDS patients

Gayà, Antoni; Esteve, Anna; Casabona, Jordi; More

AIDS . 18(2):199-204, January 23, 2004.

A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis

Wallis, Robert S; Kyambadde, Peter; Johnson, John L; More

AIDS . 18(2):257-264, January 23, 2004.

Author:
Weiser, Barbara
Author:
Wawer, Maria J
Author:
Watts, Heather
Author:
Ward, Brian J

Timing of mother-to-child transmission of HIV-1 and infant mortality in the first 6 months of life in Harare, Zimbabwe

Zijenah, Lynn S; Moulton, Lawrence H; Iliff, Peter; More

AIDS . 18(2):273-280, January 23, 2004.

Author:
Wang, Chia C

A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis

Wallis, Robert S; Kyambadde, Peter; Johnson, John L; More

AIDS . 18(2):257-264, January 23, 2004.

Author:
Vray, Murielle

Monitoring of didanosine and stavudine intracellular trisphosphorylated anabolite concentrations in HIV-infected patients

Becher, François; Landman, Roland; Mboup, S; More

AIDS . 18(2):181-187, January 23, 2004.

Author:
Violin, Michela

Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy

Violin, Michela; Cozzi-Lepri, Alessandro; Velleca, Rossella; More

AIDS . 18(2):227-235, January 23, 2004.

Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy

Violin, Michela; Cozzi-Lepri, Alessandro; Velleca, Rossella; More

AIDS . 18(2):227-235, January 23, 2004.

Recruitment, screening and characteristics of injection drug users participating in the AIDSVAX®B/E HIV vaccine trial, Bangkok, Thailand

Vanichseni, Suphak; Tappero, Jordan W; Pitisuttithum, Punnee; More

AIDS . 18(2):311-316, January 23, 2004.

Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy

Violin, Michela; Cozzi-Lepri, Alessandro; Velleca, Rossella; More

AIDS . 18(2):227-235, January 23, 2004.

Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX®B/E HIV vaccine trial in Bangkok, Thailand

van Griensven, Frits; Keawkungwal, Jaranit; Tappero, Jordan W; More

AIDS . 18(2):295-301, January 23, 2004.

Recruitment, screening and characteristics of injection drug users participating in the AIDSVAX®B/E HIV vaccine trial, Bangkok, Thailand

Vanichseni, Suphak; Tappero, Jordan W; Pitisuttithum, Punnee; More

AIDS . 18(2):311-316, January 23, 2004.

Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX®B/E HIV vaccine trial in Bangkok, Thailand

van Griensven, Frits; Keawkungwal, Jaranit; Tappero, Jordan W; More

AIDS . 18(2):295-301, January 23, 2004.

Author:
Tubiana, Roland

Benefit of treatment interruption in HIV-infected patients with multiple therapeutic failures: a randomized controlled trial (ANRS 097)

Katlama, Christine; Dominguez, Stéphanie; Gourlain, Karine; More

AIDS . 18(2):217-226, January 23, 2004.

Author:
Tsui, Rose
Author:
Thea, Donald M
Author:
Teo, Chong-Gee
Author:
Telenti, Amalio
Author:
Taskén, Kjetil

Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX®B/E HIV vaccine trial in Bangkok, Thailand

van Griensven, Frits; Keawkungwal, Jaranit; Tappero, Jordan W; More

AIDS . 18(2):295-301, January 23, 2004.

Recruitment, screening and characteristics of injection drug users participating in the AIDSVAX®B/E HIV vaccine trial, Bangkok, Thailand

Vanichseni, Suphak; Tappero, Jordan W; Pitisuttithum, Punnee; More

AIDS . 18(2):311-316, January 23, 2004.

Author:
Suter, Fredy
Author:
Susman, Ed

Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX®B/E HIV vaccine trial in Bangkok, Thailand

van Griensven, Frits; Keawkungwal, Jaranit; Tappero, Jordan W; More

AIDS . 18(2):295-301, January 23, 2004.

Author:
Stolte, Ineke G
Author:
Stek, Alice
Author:
Springer, Gayle

Thirteen years HIV-1 sentinel surveillance and indicators for behavioural change suggest impact of programme activities in south-west Tanzania

Jordan-Harder, Brigitte; Maboko, Leonard; Mmbando, Donan; More

AIDS . 18(2):287-294, January 23, 2004.

Author:
Shi, Binshan
Author:
Serwadda, David

Amino acid residue at position 13 in HLA-DR beta chain plays a critical role in the development of Kaposi's sarcoma in AIDS patients

Gayà, Antoni; Esteve, Anna; Casabona, Jordi; More

AIDS . 18(2):199-204, January 23, 2004.

Author:
Schmidt, Julie
Author:
Sasset, Lolita
Author:
Santos, Jesús

Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX®B/E HIV vaccine trial in Bangkok, Thailand

van Griensven, Frits; Keawkungwal, Jaranit; Tappero, Jordan W; More

AIDS . 18(2):295-301, January 23, 2004.

Author:
Salas, Maria

HIV-1 Nef protein in the nucleus influences adipogenesis as well as viral transcription through the peroxisome proliferator-activated receptors

Otake, Kaori; Omoto, Shinya; Yamamoto, Takuya; More

AIDS . 18(2):189-198, January 23, 2004.

Author:
Sahly, Hana MEl
Author:
Ross, Jay S
Author:
Rosen, Sydney

Thirteen years HIV-1 sentinel surveillance and indicators for behavioural change suggest impact of programme activities in south-west Tanzania

Jordan-Harder, Brigitte; Maboko, Leonard; Mmbando, Donan; More

AIDS . 18(2):287-294, January 23, 2004.

Author:
Reynes, Jacques

Benefit of treatment interruption in HIV-infected patients with multiple therapeutic failures: a randomized controlled trial (ANRS 097)

Katlama, Christine; Dominguez, Stéphanie; Gourlain, Karine; More

AIDS . 18(2):217-226, January 23, 2004.

Virological phenotype switches under salvage therapy with lopinavir–ritonavir in heavily pretreated HIV-1 vertically infected children

Galán, Isabel; Jiménez, José L; González-Rivera, Milagros; More

AIDS . 18(2):247-255, January 23, 2004.

Author:
Reilly, Marie
Author:
Ravasio, Laura
Author:
Ramos, José T

Virological phenotype switches under salvage therapy with lopinavir–ritonavir in heavily pretreated HIV-1 vertically infected children

Galán, Isabel; Jiménez, José L; González-Rivera, Milagros; More

AIDS . 18(2):247-255, January 23, 2004.

Monitoring of didanosine and stavudine intracellular trisphosphorylated anabolite concentrations in HIV-infected patients

Becher, François; Landman, Roland; Mboup, S; More

AIDS . 18(2):181-187, January 23, 2004.

Author:
Poli, Guido
Author:
Pohle, Monika

A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis

Wallis, Robert S; Kyambadde, Peter; Johnson, John L; More

AIDS . 18(2):257-264, January 23, 2004.

Author:
Piwoz, Ellen G

Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX®B/E HIV vaccine trial in Bangkok, Thailand

van Griensven, Frits; Keawkungwal, Jaranit; Tappero, Jordan W; More

AIDS . 18(2):295-301, January 23, 2004.

Recruitment, screening and characteristics of injection drug users participating in the AIDSVAX®B/E HIV vaccine trial, Bangkok, Thailand

Vanichseni, Suphak; Tappero, Jordan W; Pitisuttithum, Punnee; More

AIDS . 18(2):311-316, January 23, 2004.

Benefit of treatment interruption in HIV-infected patients with multiple therapeutic failures: a randomized controlled trial (ANRS 097)

Katlama, Christine; Dominguez, Stéphanie; Gourlain, Karine; More

AIDS . 18(2):217-226, January 23, 2004.

Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy

Violin, Michela; Cozzi-Lepri, Alessandro; Velleca, Rossella; More

AIDS . 18(2):227-235, January 23, 2004.

Author:
Paul, Sudhir
Author:
Parry, John V
Author:
Otake, Kaori

HIV-1 Nef protein in the nucleus influences adipogenesis as well as viral transcription through the peroxisome proliferator-activated receptors

Otake, Kaori; Omoto, Shinya; Yamamoto, Takuya; More

AIDS . 18(2):189-198, January 23, 2004.

Author:
Osner, Natasha
Author:
Orelind, Karin

Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX®B/E HIV vaccine trial in Bangkok, Thailand

van Griensven, Frits; Keawkungwal, Jaranit; Tappero, Jordan W; More

AIDS . 18(2):295-301, January 23, 2004.

Author:
Omoto, Shinya

HIV-1 Nef protein in the nucleus influences adipogenesis as well as viral transcription through the peroxisome proliferator-activated receptors

Otake, Kaori; Omoto, Shinya; Yamamoto, Takuya; More

AIDS . 18(2):189-198, January 23, 2004.

A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis

Wallis, Robert S; Kyambadde, Peter; Johnson, John L; More

AIDS . 18(2):257-264, January 23, 2004.

Author:
Okuyama, Harumi

HIV-1 Nef protein in the nucleus influences adipogenesis as well as viral transcription through the peroxisome proliferator-activated receptors

Otake, Kaori; Omoto, Shinya; Yamamoto, Takuya; More

AIDS . 18(2):189-198, January 23, 2004.

Author:
Okada, Noriko

HIV-1 Nef protein in the nucleus influences adipogenesis as well as viral transcription through the peroxisome proliferator-activated receptors

Otake, Kaori; Omoto, Shinya; Yamamoto, Takuya; More

AIDS . 18(2):189-198, January 23, 2004.

HIV-1 Nef protein in the nucleus influences adipogenesis as well as viral transcription through the peroxisome proliferator-activated receptors

Otake, Kaori; Omoto, Shinya; Yamamoto, Takuya; More

AIDS . 18(2):189-198, January 23, 2004.